On Monday, July 24, the next meeting of the Transparency Council.
The agenda includes:
Preparation of an opinion on the appropriateness of making comprehensive changes to the content of the drug program B.4 "Treatment of patients with advanced colorectal cancer (ICD-10: C18 - C20)".
Content locked
To gain access to the complete English section of the Medexpress.pl, kindly reach out to us at [email protected].
If you already have an account, please log in
